Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zalypsis enters phase I

Jan. 25, 2005

Preclinical data indicate efficacy of the VEGF pathway-targeted siRNA, ICS-283

Jan. 25, 2005

Agents for the treatment of estrogen-dependent diseases described in a patent

Jan. 24, 2005

Phase I study investigates pralatrexate in NSCLC

Jan. 24, 2005

New data on the pharmacokinetics of 667-Coumate in rats

Jan. 24, 2005

Update on the antitumor effects of bortezomib in MM and non-Hodgkin's lymphoma

Jan. 21, 2005

Not approvable letter for Marqibo

Jan. 21, 2005

AN-152 enters clinical development

Jan. 21, 2005

Teduglutide is a potential anti-mucositis therapeutic for chemotherapy patients

Jan. 21, 2005

GSK prepares and tests novel compounds for proliferative diseases

Jan. 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026